ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000841.1|Alanylclavam_1 # 1 # 1644 # 1 # ID=1_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.702	BGC0000841.1|Alanylclavam_1 	1	1644	+	Loose	300	28.8758	Escherichia coli soxR with mutation conferring antibiotic resistance	43.33	3003381	protein overexpression model	n/a	n/a	fluoroquinolone antibiotic; cephalosporin; glycylcycline; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; disinfecting agents and antiseptics	antibiotic target alteration; antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump; major facilitator superfamily (MFS) antibiotic efflux pump; resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCTGGAACGTCTTCACCAGTACGGTGTCGACCATGTATTCGGCGTCGTCGGCCGGGAGGCGTCCGCCATTCTCTTCGACGAGGTCGAAGGACTCGACTTCGTCCTGACCCGGCACGAGTTCACCGCCGGGGTGATGGCGGACGTCCTCGCCCGGATCACCAACCGCCCCCAGGCGTGCTTCGCGACCCTGGGCCCCGGCATGACCAACCTGGCCACCGGCGTCGCCACCTCCGCCCTGGACCGCAGCTCGGTCATCGCGCTGGCCGCGCAGTCCGAGTCGTACGACTGCTACCCCAACGTCACCCACCAGTGCCTGGACAGCACCGCCGTGATGGGCCCGCTGACCAAGTTCAGCGTCCAGCTCGAACGCGGCGAGGACATCGTCAACCTCGTCGACAGCGCCGTCCTCAACAGCCGGATCGAGCCCGTGGGTCCCAGCTTCATCAGCCTGCCGGTCGACCTCCTCGGCGCCGAGCTGAACGGCACCCCCACCGACGCCCCCCTGGTCCGGGCCACCGCCACCCACGCCCTGGACGCCGACTGGCGCGCCCGCCTCGACGAGGCCGCTGAGCTGGTGCGCGAGGCCGAGAACCCCCTCCTCGTCGTCGGTAGCGCCGTCATCCGCGCCGGGGCCGTCGACGCCCTGCGCGCCCTCGCCGAGCGGCTGAACATCCCCGTCGTCACCACCTACACCGCCAAGGGCGTCCTGCCGCACGACCACCCGCTCAACTACGGCGCCATCAGCGGCTACATGGACGGCATTCTCGGCCACCCGGCCCTCGACGAGATCTTCGGCCCCGCCGACCTCCTCCTGGCGATCGGCTACGACTACGCCGAGGACCTGCGCCCCTCCATGTGGACGCGGGGCCGGGCCAAGACCACGGTCCGGGTCGCCCCCGAGGTCAACCCGATCCCGGAGCTGTTCCGCGCCGACATCGACATCGTCACCAACGTCGCCGAATTCGTCACCGCGCTCGACGACGCGACCTCGGGCCTCGCCCCCAAGACCCGGCACGACCTCAGCGCCCTGCGCGCCCGCGTCGCCGAATTCCTCGCCGACCCCACCGAGTACGAGGACGGCATGCGGGTCCACCAGGTGATCGACTGCATGAACTCCGTCCTCGACAACGGCACCTTCGTCAGCGACATCGGCTTCTTCCGCCACTACGGCGTGCTCTTCGCCAAGTCCGACCAGCCGTACGGATTCCTCACCTCCGCGGGCTGCTCCAGCTTCGGCTACGGACTGCCCGCCGCCATGGCCGCCCAGATCGCCCGGCCCGGCGAGCCCGTCTTCCTCATCGCGGGCGACGGCGGCTTCCACTCCAACAGCGCCGACATCGAGACGGCCGTGCGCCTGGGCCTGCCGATCGTCATGGTCGTCGTCAACAACGACCGCAACGGCCTGATCGAGCTGTACCAGAACCTCGGACACCAGCGCTCCCACGCCCCCGCCGTCGGCTTCGGAAGCGTCGACTTCGTCCAGCTCGCCGAGGCCAACGGCTGCGAGGCCGTCCGCGCCACCGACCGCACCTCGCTGCTCGCCGCCCTCACCAAGGGCGCCGGACTCGGCCGCCCGTTCCTGATCGAGGTACCGGTGGCCTACGACTTCCAGTCCGGCGGTTTCGCCGCCCTGGCCATCTGA	MLERLHQYGVDHVFGVVGREASAILFDEVEGLDFVLTRHEFTAGVMADVLARITNRPQACFATLGPGMTNLATGVATSALDRSSVIALAAQSESYDCYPNVTHQCLDSTAVMGPLTKFSVQLERGEDIVNLVDSAVLNSRIEPVGPSFISLPVDLLGAELNGTPTDAPLVRATATHALDADWRARLDEAAELVREAENPLLVVGSAVIRAGAVDALRALAERLNIPVVTTYTAKGVLPHDHPLNYGAISGYMDGILGHPALDEIFGPADLLLAIGYDYAEDLRPSMWTRGRAKTTVRVAPEVNPIPELFRADIDIVTNVAEFVTALDDATSGLAPKTRHDLSALRARVAEFLADPTEYEDGMRVHQVIDCMNSVLDNGTFVSDIGFFRHYGVLFAKSDQPYGFLTSAGCSSFGYGLPAAMAAQIARPGEPVFLIAGDGGFHSNSADIETAVRLGLPIVMVVVNNDRNGLIELYQNLGHQRSHAPAVGFGSVDFVQLAEANGCEAVRATDRTSLLAALTKGAGLGRPFLIEVPVAYDFQSGGFAALAI	MEKKLPRIKALLTPGEVAKRSGVAVSALHFYESKGLITSIRNSGNQRRYKRDVLRYVAIIKIAQRIGIPLATIGEAFGVLPEGHTLSAKEWKQLSSQWREELDRRIHTLVALRDELDGCIGCGCLSRSDCPLRNPGDRLGEEGTGARLLEDEQN	355.19	gnl|BL_ORD_ID|1973|hsp_num:0	1005			171	261	tigecycline; ciprofloxacin; tetracycline; rifampin; chloramphenicol; ampicillin; nalidixic acid; norfloxacin; cefalotin; triclosan
BGC0000841.1|Alanylclavam_2 # 1668 # 3251 # 1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=AGGAG/GGAGG;rbs_spacer=11-12bp;gc_cont=0.756	BGC0000841.1|Alanylclavam_2 	1668	3251	+	Loose	400	29.261	Erm(38)	32.93	3000601	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; streptogramin A antibiotic; streptogramin B antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGCCCGGCCCCGACCTCGTGTACGGATTCCGGGTGCGCATCGGCACCGAGGGCCGCCCCGGCGGCGGCCCCGGCGGTCACTCCGAACCCGGCAGCGCACCCCGCTTCGCCGTCCGCGGGACCCATGTCCCCGTGCACGACGGCACCGCGTACCCGCTCTGGAGCGGAACGGCCGTGACCCTGGGCCGTCCGCCCGTCCTGGTCGCCGACGGCCAGGTCCGGCTGCTCCTGGCGGGCGAGCTGTACAACCGCGCCGAGCTGACCGGAGCGCTCGGCGGCTCCTCTGCCGCCCTCGGCGACGCCGAACTGCTGCTGGCCGCCTGGCGGCGCTGGGGCCCCGGGGCCTTCCGGCTCCTGAACGGACGGTTCGCCGCACTGCTCACCGACGCCTCCACCGGCGCGACCGTCGCGGCCACCGACCACGCCGGTTCGGTACCGCTGTGGCTGCGCGCCGACGTGACGGGGCTGAGCGCCGCCACCGAGGCGAAGACCCTGGCGCACGAGCCGGGCCGGCCGCTGGGCCTGTCCGGCACCCACACCGCGCCGGGGGCGGCGGGCGTCTGCCGGGTCCCCGCCGGGACCGCCCTCCTGCTGCACGGAGTCGGCGGCTCCGACATCACCGCCAGGGCGGTCCGCACCTGGACACCCCCGCTCTCCCGGGCGCTGCCCGGCGAACGGGAGGCGGTGGACCTGGTCGGCGAACGCCTCGCCACGGCGGTCCGCACCCGGCTGCGCGGCGGGGAGGCGGCCCCCACCGTCGTCCTGTCCGGCGGCATCGACTCCGGGGGAGTCGCCGCCCACACGGCGGCCCTGGCACCCGGGACACGGTCCGTGTCGATGGGCACCGAGGTGTCCGACGAGTTCGACGCGGCCCGCTCGGTCGCCGTCCACCTGGGCACCGCGCACAGCGAGATCCGGCTCCACTCGGCCGAACTCGTCAGGGAACTGCCCTGGGCGGTCGCCGCCGCGGAGATCACCGACCCCACGGTCCTGGAGTACCTGCTGCCGCTCGTCGCCCTCTACCGGCGGCTCGACACCGGGCCGCTCCGCATCCTCACCGGGTACGGCGCCGACATCCCGCTCGGCGGTATGCACCGGCGCACGGCCTCGCTCTGGTCCCTCGACGACGAGATCGCGGGCGACATGGCGGGCTTCGACGGCCTCAACGAGATGTCCCCCGTCCTCGCGGGCATCGCCGGGAAGTGGACCACCCACCCGTACTGGGACCGCGCGGTCCTGGACGCGCTGGTCTCCCTCGAACCCGGGCTCAAACGCCGGCGGGGCACCGACAAGTGGGTGTTGCGGCAGGCCCTCTCCGGCCTGCTGCCCGCCGAGACCGTGGCCCGCCCCAAGCTGGGCATCCACGAGGGGTCCGGCACCACCAGCGCGTGGACCGGACTGCTCCTCGCCGAAGGGATCCGGCGCGACGAGGTGACGGCCGTCAAGGGCGCCATGGCACGGCGCCTGTACGACGCGGTGGTCATCGACACGGTGCCGCCGGAGGACGTGGACTTCGGCGAGACGGTGCGGCGCTCCGTCGACGCGGTGCGCAGGCTCAGGCTCCAGGGCCGGGTGGTCGTATGA	MPGPDLVYGFRVRIGTEGRPGGGPGGHSEPGSAPRFAVRGTHVPVHDGTAYPLWSGTAVTLGRPPVLVADGQVRLLLAGELYNRAELTGALGGSSAALGDAELLLAAWRRWGPGAFRLLNGRFAALLTDASTGATVAATDHAGSVPLWLRADVTGLSAATEAKTLAHEPGRPLGLSGTHTAPGAAGVCRVPAGTALLLHGVGGSDITARAVRTWTPPLSRALPGEREAVDLVGERLATAVRTRLRGGEAAPTVVLSGGIDSGGVAAHTAALAPGTRSVSMGTEVSDEFDAARSVAVHLGTAHSEIRLHSAELVRELPWAVAAAEITDPTVLEYLLPLVALYRRLDTGPLRILTGYGADIPLGGMHRRTASLWSLDDEIAGDMAGFDGLNEMSPVLAGIAGKWTTHPYWDRAVLDALVSLEPGLKRRRGTDKWVLRQALSGLLPAETVARPKLGIHEGSGTTSAWTGLLLAEGIRRDEVTAVKGAMARRLYDAVVIDTVPPEDVDFGETVRRSVDAVRRLRLQGRVVV	MSTPHHGRHELGQNFLSDRRVIADIVEIVSRTNGPIIEIGAGDGALTIPLQRLARPLTAVEVDARRARRLAQRTARSAPGPASRPTEVVAADFLRYPLPRSPHVVVGNLPFHLTTAILRRLLHGPGWTTAVLLMQWEVARRRAAVGGATMMTAQWWPWFEFGLARKVSAASFTPRPAVDAGLLTITRRSRPLVDVADRARYQALVHRVFTGRGHGMAQILQRLPTPVPRTWLRANGIAPNSLPRQLSAAQWAALFEQTRLTGAQRVDRPRDVQHGRAHRRRGGEVDRPATHHKQTGPVVGQRQPQRGRDADADPDDQRTAPPVTRHHQGERRDEDQADHQDRPLTGEHLAGEFLWRHASFDSSASTTLVSRKARVNGPTPPGLGDT	136.53	gnl|BL_ORD_ID|1004|hsp_num:0	1097			228	474	erythromycin; roxithromycin; lincomycin; telithromycin; clarithromycin; clindamycin; tylosin; spiramycin; azithromycin; dirithromycin; pristinamycin IA; quinupristin; virginiamycin M1; madumycin II; griseoviridin; dalfopristin; pristinamycin IB; virginiamycin S2; pristinamycin IC; vernamycin C; patricin A; patricin B; ostreogrycin B3; oleandomycin
BGC0000841.1|Alanylclavam_3 # 3248 # 4621 # 1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=GGxGG;rbs_spacer=3-4bp;gc_cont=0.753	BGC0000841.1|Alanylclavam_3 	3248	4621	+	Loose	400	27.7202	ErmR	28.74	3000594	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; streptogramin A antibiotic; streptogramin B antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGAGCGGCCAGAACGGCACCGGTGGCCAGAACGGCACCGGCGGCGGCAACGGCACCGGCGGCGGCGCGGACGGTGCAGCGGGCGTGGGCGCGGGCACCGGCCCGCAGAGCGGCAACGGCCGCAGGAACGGCAGGAGCGGTCTCGGAGGGAGGGGCAGCCGCGGCCCGGACGGCGCCGCGGGCGCGGGAACGGGATTCCACGCGGGAACGGGAGCCCGTTCGGGAACGGGGGTCGGCACGGGAACGGGAGCCCGCACGGGGTGGCCGGGCGTCGGTACGGGAACGGGAGCAGGGCCGGGTGCGCGGGGAACGGCCAGGGTGTCCACCGCCGTCTCCCCGCGCTACGCCCAACCGGCGACCTTCATGCGGCTGCGCCACCGGCCCGACCCGATCGGCCATGACGTGGTGGTCGTCGGCGCCCCGTACGACGGAGGCACCAGCTACCGGCCCGGCGCGCGGTTCGCGCCGCGCGCCATCCGGCACGAGTCCAGCCTGATCCACGGCGTCGGCATCGACCGGGGCCCAGGGGTCTTCGACCGGATCGACGTGGTCGACGGGGGCGACATCGACCTCAGCCCCTTCTCGATGGACCTGGCGATGGACACCGCGACGGTCGCCCTGACCCGGCTCCTGGAACGCAACGACGCGTTCCTGATGCTGGGCGGGGACCACTCGCTCTCCCTGGCCGCCCTGCGCGCCGTGCACGCCCGCCACGGCCGGGTCGCCGTCCTGCACCTGGACGCGCACAGCGACACCAACCCACCCGTCTACGGCGGCACCTACCACCACGGCACCCCCTTCCGCTGGGCCATCGAAGAGGGCCTGGTGGACCCGGAGCGCCTGGTCCAGGTCGGCATCCGCGGCCACAATCCGCGGCCCGACTCCCTGGACTACGCGCGCGGGCACGGCGTCAGCATCGTCACCGCCGCCGACTTCACCCGGCGCTCACCGCGCGGCATCGCCGAGCAGATCCGGCGCACCGTCGGCGGCCTGCCGCTGTACGTCTCCGTCGACATCGACGTCGTCGACCCGGCGTACGCCCCGGGCACCGGCACACCGGCCCCCGGCGGGCTGTCCTCGCGCGAGGTGCTGACCCTGCTCGACGTGGTCGGGCAGCTCAGGCCCGTCGGCTTCGACGTGGTCGAGGTGTCCCCGGCGTACGACCCGTCGGGGATCACCTCCCTGCTGGCGGCGGAGATCGGGGCCGAACTGCTCTACCAGTACGCCCGCGCCACCACGTCGCCCGCGTCGGCACCGGTGGACTCTCCCCTGCCACCGGGGGCGGCGGCGGACGACGCCGAGAACGCCGAGAACGCGGTGGACGCGGTGGACGCCGAGAGCGCCGTGGACTTCGCCGGGCAGCGGTGGGGGTAG	MSGQNGTGGQNGTGGGNGTGGGADGAAGVGAGTGPQSGNGRRNGRSGLGGRGSRGPDGAAGAGTGFHAGTGARSGTGVGTGTGARTGWPGVGTGTGAGPGARGTARVSTAVSPRYAQPATFMRLRHRPDPIGHDVVVVGAPYDGGTSYRPGARFAPRAIRHESSLIHGVGIDRGPGVFDRIDVVDGGDIDLSPFSMDLAMDTATVALTRLLERNDAFLMLGGDHSLSLAALRAVHARHGRVAVLHLDAHSDTNPPVYGGTYHHGTPFRWAIEEGLVDPERLVQVGIRGHNPRPDSLDYARGHGVSIVTAADFTRRSPRGIAEQIRRTVGGLPLYVSVDIDVVDPAYAPGTGTPAPGGLSSREVLTLLDVVGQLRPVGFDVVEVSPAYDPSGITSLLAAEIGAELLYQYARATTSPASAPVDSPLPPGAAADDAENAENAVDAVDAESAVDFAGQRWG	MAGPQDRPRGRGPSSGRPQRPVGGRSQRDRDRRVLGQNFLRDPATIRRIADAADVDPDGLVVEAGPGEGLLTRELARRAGRVRTYELDQRLARRLSTDLAQETSIEVVHADFLTAPHPEEPFQFVGAIPYGITSAIVDWCLTAPTLTSATLVTQQEFARKRTGDYGRWTALTVTTWPTFEWQYVAKVDRTLFTPVPRVHSAIMRLRRRPQPLLRDAAARSRFADMVEIGFVGKGGSLYRSLTREWPRSKVDSAFARADVHHDEIVAFVHPDQWITLFQLLDGSRGGAARGPGDQRGRRGRPGGGPRPDGRAGGGPRRDAGGRRTGDGRGGRPRPPRGGQA	134.41	gnl|BL_ORD_ID|1473|hsp_num:0	1612			597	858	erythromycin; roxithromycin; lincomycin; telithromycin; clarithromycin; clindamycin; tylosin; spiramycin; azithromycin; dirithromycin; pristinamycin IA; quinupristin; virginiamycin M1; madumycin II; griseoviridin; dalfopristin; pristinamycin IB; virginiamycin S2; pristinamycin IC; vernamycin C; patricin A; patricin B; ostreogrycin B3; oleandomycin
BGC0000841.1|Alanylclavam_4 # 4813 # 5958 # -1 # ID=1_4;partial=00;start_type=GTG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.771	BGC0000841.1|Alanylclavam_4 	4813	5958	-	Loose	1200	27.335	TaeA	35.48	3003986	protein homolog model	n/a	n/a	pleuromutilin antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	GTGCACCACGGTCACGCCGGGATCAGGGGGTCCCACGCGGACCTCGCCGTCATCGCCTCCGACGTTCCCGCGGCGGTCGGCGCGGTGTTCACCCGTTCGCGGTTCGCCGCGCCGAGTGTGCTGCTCAGCCGGGACGCGGTCGCCGACGGGATCGCCCGGGGCGTGGTGGTGCTGTCCGGCAACGCCAACGCCGGGACGGGCCCGCGGGGGTACGAGGACGCCGCGGAGGTGCGCCATCTGGTGGCCGGGATCGTCGACTGCGACGAGAGGGATGTGCTGATCGCCTCCACGGGACCCGTCGGCGAGCGGTATCCGATGTCCCGTGTCCGGGCCCATCTGCGGGCGGTGCGCGGGCCCTTACCGGGTGCCGACTTCGACGGCGCGGCGGCGGCCGTGCTGGGCACCGCGGGCGCCCGTCCCACGATCCGGCGGGCGCGGTGCGGCGACGCGACGCTGATCGGTGTCGCCAAGGGCCCGGGTACGGGCCCGGCGGAGCAGGACGACCGGTCGACGCTGGCGTTCTTCTGCACGGACGCCCAGGTGAGCCCCGTCGTCCTCGACGACATCTTCCGCCGGGTCGCGGACCGCGCCTTCCACGGGCTGGGCTTCGGCGCCGACGCCTCCACCGGCGACACGGCGGCCGTTCTCGCCAACGGGCTCGCGGGCCGGGTGGACCTCGTCGCGTTCGAACAGGTCCTGGGCGCGCTGGCGCTGGACCTGGTCAGGGACGTCGTCCGGGACAGCGGCTGCGGCGGCGCCCTGGTCACGGTGCGGGTCACCGGGGCCCACGACACCGAGCAGGCCGGGCGCGTGGGCCGGGCGGTGGTCGACGCGCCGTCGCTGAGGGCCGCGGTGCACGGCCCGGCACCCGACTGGGCGCCGGTCGCCGCCGTGGCGGGTGGACACGGGGACGAAGGCCCCGGCCGGTCTCCCGGGCGGATCACGATCCGGGTCGGCGGCCGGGAGGTCTTCCCCGCCCCCCGCGACCGGGCCCGCCCGGACGCCGTCACCGCGTATCCGCACGGCGGCGAGGTGACCGTCCATATCGACCTCGGTGTCCCGGGCCGGGCGCCCGGCGCGTTCACGGTCCACGGCTGCGACCTCCTGGCGGGGTACCCGCGCCTCGGCGCCGGCCGGGCCGTCTGA	MHHGHAGIRGSHADLAVIASDVPAAVGAVFTRSRFAAPSVLLSRDAVADGIARGVVVLSGNANAGTGPRGYEDAAEVRHLVAGIVDCDERDVLIASTGPVGERYPMSRVRAHLRAVRGPLPGADFDGAAAAVLGTAGARPTIRRARCGDATLIGVAKGPGTGPAEQDDRSTLAFFCTDAQVSPVVLDDIFRRVADRAFHGLGFGADASTGDTAAVLANGLAGRVDLVAFEQVLGALALDLVRDVVRDSGCGGALVTVRVTGAHDTEQAGRVGRAVVDAPSLRAAVHGPAPDWAPVAAVAGGHGDEGPGRSPGRITIRVGGREVFPAPRDRARPDAVTAYPHGGEVTVHIDLGVPGRAPGAFTVHGCDLLAGYPRLGAGRAV	MNILTVEQVTKSYGDKILFQDASFGMEDQDKIGIIGVNGTGKSTFLRVIAGLEPPDSGKISMGNRIRVRYLAQNPEFDPDKTVLQQVFEGDLPEMKAVREYTETMELLELHPSHEELQQKLLKLNQTLETLQAWQLESDAKTILSKLGIRNYEAKMGTLSGGQRKRVALAAALIQPSDLLILDEPTNHIDNESVAWLEQYLQKRRGALLMITHDRYFLDRVANVMLELDHGRLFRYEANYSRFLELKAEREEREAASEQKRQNLLRSELAWIRRGAKARTTKQKARIERFEKLKDQEMVHSSGELDVSVASTRLGRKILEIEGLRMKIDDKTLIQDLSYIAVPEDRIGIVGPNGSGKSTLLNLIAGRIQPGGGEVVLGPTVKLGYFTQEHQEMDGSQRVIEYIKDEAEVVRTADGSAITAAQMLERFLFPPALQWTPIAKLSGGEKRRLYLLRVLMSAPNVLLLDEPTNDLDIQTLSVLEQYLDEFPGVCIVVSHDRFFLDRTVDKIMAFEGDGQIRVHVGSYSEYAEWMQRHGGEASGSKAEASIAKSASGSSDGTDSDSAKEAPRERLKFSYKEQREFDQIDGLIEDTESKLASIQSEMETAGSDAARLQELMKAQEETERELEHLMERWTYLNELAEKIEQSKKS	58.80	gnl|BL_ORD_ID|2230|hsp_num:0	2522			1242	1335	pleuromutilin
BGC0000841.1|Alanylclavam_5 # 6622 # 8103 # -1 # ID=1_5;partial=00;start_type=TTG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.734	BGC0000841.1|Alanylclavam_5 	6622	8103	-	Loose	1900	27.7202	MexI	26.47	3000808	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; tetracycline antibiotic; disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	TTGGACACGTACGCAGCGGATACGTACCCGCGGTCCGGCACCCACCCCGAGCCGCGTCCCGACGCACCTCCCCACGCGCGTCCCGGGACCCGTCCCGGCACCCGTTCCGAGCCGCGCCCGGACCCGGGCGCCGAGGCCGCGTGGCTGCTCGCGGCGGACCGCGCCCATATGTTCCACCCGGTCCTGCCCCGGGGCCGCGAGGACCGCACCGTTCTGGTCTCCGGCCGCGGCTGCACCGTACGGGACACCGAAGGGCGCACCTATCTCGACGCCTCGTCGGTGCTCGGACTGACCCAGATCGGCCATGGACGTGAGGAGATCGCGCAGGCCGCCGCCGAGCAGATGCGGACACTCGGTCACTTCCACACCTGGGGCACCATCAGCAACGACAAGGCCATCCGACTGGCCGCGCGCCTCACCGACCTGGCGCCCCAGGGTCTCCAGCGCGTCTACTTCACCAGCGGCGGCGGCGAGGGCGTCGAGATCGCCCTGCGCATGGCCCGTTACTTCCACCACCGCACCGGCAGCCCGGAGCGCACCTGGATCTTGTCGCGCCGCACCGCCTACCACGGCATCGGCTACGGCAGCGGTACGGTGTCGGGCTCGCCCGCCTACCAGGACGGGTTCGGCCCGGTGCTGCCCCATGTGCACCACCTCACGCCGCCCGACCCGTACCACGCCGAGCTGTACGACGGCGAGGACGTCACGGAGTACTGCCTGCGCGAACTCGCCCGCACCATCGACGAGATCGGCCCCGGGCGGATCGCCGCGATGATCGGGGAGCCGGTCATGGGCGCGGGCGGCGCCGTCGTCCCGCCGCCGGACTACTGGCCGCGCGTCGCCGCGCTGCTGCGCTCCCACGGCATCCTGCTGATCCTGGACGAGGTCGTCACCGCGTTCGGCCGCACGGGGACCTGGTTCGCGGCCGAGCACTTCGGGGTGACCCCCGATCTGCTGGTGACCGCGAAGGGCATCACCTCCGGGTATGTCCCGCACGGGGCGGTGCTCCTGACCGAGGAGGTCGCGGACGCCGTGAACGGGGAGACGGGGTTCCCGATCGGCTTCACCTATACCGGTCACCCCACGGCGTGCGCCGTCGCGCTCGCCAATCTCGACATCATCGAACGGGAAGGGCTGCTGGAGAACGCGGTGAAGGTGGGCGACCACCTCGCCGGGCGGCTGGCGGCCCTGCGCGGGCTGCCCGCCGTGGGGGACGTCCGGCAACTGGGCATGATGCTCGCCGTCGAGCTGGTGTCGGACAAGACGGCCCGCACCCCGCTGCCGGGCGGCACCCTCGGGGTCGTGGACGCGCTGCGCGAGGACGCGGGCGTCATCGTCCGGGCCACGCCGCGCTCCCTGGTCCTCAATCCGGCGCTCGTGATGGACCGGGCCACGGCGGACGAGGTGGCGGACGGGCTGGACTCGGTGCTGCGGCGGCTGGCACCCGACGGGCGGATCGGCGCGGCCCCCCGGCGGGGGTGA	MDTYAADTYPRSGTHPEPRPDAPPHARPGTRPGTRSEPRPDPGAEAAWLLAADRAHMFHPVLPRGREDRTVLVSGRGCTVRDTEGRTYLDASSVLGLTQIGHGREEIAQAAAEQMRTLGHFHTWGTISNDKAIRLAARLTDLAPQGLQRVYFTSGGGEGVEIALRMARYFHHRTGSPERTWILSRRTAYHGIGYGSGTVSGSPAYQDGFGPVLPHVHHLTPPDPYHAELYDGEDVTEYCLRELARTIDEIGPGRIAAMIGEPVMGAGGAVVPPPDYWPRVAALLRSHGILLILDEVVTAFGRTGTWFAAEHFGVTPDLLVTAKGITSGYVPHGAVLLTEEVADAVNGETGFPIGFTYTGHPTACAVALANLDIIEREGLLENAVKVGDHLAGRLAALRGLPAVGDVRQLGMMLAVELVSDKTARTPLPGGTLGVVDALREDAGVIVRATPRSLVLNPALVMDRATADEVADGLDSVLRRLAPDGRIGAAPRRG	MTFTDLFVRRPVLALVVSTLILLLGLFSLGKLPIRQYPLLESSTITVTTEYPGASADLMQGFVTQPIAQAVSSVEGIDYLSSTSVQGRSVVTIRMLLNRDSTQAMTETMAKVNSVRYKLPERAYDSVIERSSGETTAVAYVGFSSKTLPIPALTDYLSRVVEPMFSSIDGVAKVQTFGGQRLAMRLWLDADRLAGRGLTASDVAEAIRRNNYQAAPGMVKGQYVLSNVRVNTDLTNVDDFREMVIRNDGNGLVRLRDVGTVELGAAATETSALMDGDPAVHLGLFPTPTGNPLVIVDGIRKLLPEIQKTLPPDVRVDLAYETSRFIQASIDEVVRTLVEALLIVVLVIYLCLGSLRSVLIPVATIPLSMLGAAALMLAFGFSVNLLTLLAMVLAIGLVVDDAIVVVENVHRHIEEGKSPVAAALIGAREVAGPVIAMTITLAAVYTPIGLMGGLTGALFREFALTLAGAVIVSGVVALTLSPVMSSLLLQAHQNEGRMGRAAEWFFGGLTRRYGQVLEFSLGHRWLTGGLALLVCISLPLLYSMPKRELAPTEDQAAVLTAIKAPQHANLDYVELFARKLDQVYTSIPETVSTWIINGTDGPAASFGGINLAAWEKRERDASAIQSELQGKVGDVEGSSIFAFQLAALPGSTGGLPVQMVLRSPQDYPVLYRTMEEIKQKARQSGLFVVVDSDLDYNNPVVQVRIDRAKANSLGIRMQDIGESLAVLVGENYVNRFGMEGRSYDVIPQSLRDQRFTPQALARQFVRTQDGNLVPLSTVVRVALQVEPNKLIQFDQQNAATLQAIPAPGVSMGQAVAFLDDVARGLPAGFSHDWQSDSRQYTQEGNTLVFAFLAALVVIYLVLAAQYESLADPLIILITVPLSICGALLPLALGYATMNIYTQIGLVTLIGLISKHGILMVEFANELQLHERLDRRAAILRAAQIRLRPVLMTTAAMVFGLVPLLFASGAGAASRFGLGVVIVSGMLVGTLFTLFVLPTVYTLLARNHAEVDKSPRSRQLAEADLLVNKA	47.91	gnl|BL_ORD_ID|4683|hsp_num:0	1647			888	1188	acriflavine; tetracycline; norfloxacin
BGC0000841.1|Alanylclavam_6 # 8276 # 10858 # -1 # ID=1_6;partial=00;start_type=GTG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.728	BGC0000841.1|Alanylclavam_6 	8276	10858	-	Loose	950	29.6462	msrC	35.29	3002819	protein homolog model	n/a	n/a	macrolide antibiotic; streptogramin antibiotic; streptogramin B antibiotic	antibiotic target protection	msr-type ABC-F protein	GTGTCGGACGTCTTCGCATCCGAGAAGAGTTCGCCCGGTGTCCGGACCCGCGCGGCAACGTCCCCACCGCGCTCTGTCATCAGCGCCGTCGGCGCCGTCAGCCACGCAGAGAAGATCGGATACGCAGTGTACGAGTGCAGCGATGAGGTTCGTCACGACGTCCCCGGCCTGCCGGGTCCGTCACCGTCCATCACCGTCCTGGGCTGTCTGGGCGTACGCGCCGACGGCCGGAAACTGGAGCTGGGCCCTCCGCGTCAGCGGGCCGTTTTCGCCCTGCTGCTCATCAACGCGGGCAGTGTGGTGCCGGTCGACTCGATCGTCTTCCGTATCTGGGGCAACTCACCACCGGGCGCGGTCACCGCGACGCTCCAGTCCTATGTGTCCCGGCTGCGGAAACTCCTGGCCGAGTGTGTGCTCCCGGACGGTTCGACACCCGAACTGCTGCACCAGCCGCCGGGCTACACCCTCGCGCTCGGCACCGAGCACATCGACGCGAACCGTTTTGAGCAGGCCATCAGGACAGGGCGCCGGCTCTCGCGCGAGGAGCAGCACCAGGAGGCGCGGGCCGTGCTCTGCCAGGCCCTGCTGAGCTGGGGCGGGACACCGTACGAGGAGCTGAGCGCGTACGACTTCGCCGTCCAGGAGGCCAATCGGCTGGAGCAGCTCCGGCTGGGCGCCGTGGAGACATGGGCGCACTGCTGTCTGCGGCTGGGGCGGGACGAGGAGGTGATGGACCAGCTCAAGCCGGAGGTGCAGCGCAATCCGCTGCGGGAGCGGCTGATCGGGCAGCTCATGCAGGCGCAGTACCGGCTGGGGTGCCAGGCGGACGCGCTCAGGACGTACGAGGCGACGCGGCGGGCCCTGGCCGAGGAGCTGGGGACCGATCCGGGCAAGGAGCTGGCGGCGCTGCACGCGGCGATCCTGCGTCAGGACAACGGTCTGGACCGCGTCGTCCCGGCGTCCGCGCCGCCGTCGGCGGGGGTCGGGCGGGGGGCCGTGACGGTGTCGGTCCCGGCACAGCGGTCGAGGCCGTTGACGCGGCCGGTGGCGGGGCGGGCGCGGGTCCCGGGGGCGATGACGGTGGCGGCGGGCGCGGGGGCGGCCCCCGCGTCCGCCTCCGGCTCCGTTTCCGCGTCCGTTTCCGGCTCCGGCTCCGGCTCCGGCTCCGCTCCTGCGTCGGTTCCCACCTTCTTTCCCGGCTCCGTTTCTGGCTCGGCGTCCGTTGCCGCGTCCGTAGCCGCGCCCGTTTCCGGCCATGTCTCCGGGCCCGGGTCCGCTTTCGGGTCCGTGGCGCTCCACCGGCCGCAGACCCTCCGGGGCGAGCCGGTCCACGGGGGCGCGCAGGGGATGCGCACCGGGCAGGTGTTCCCCACGCTGCCGCCGTTCGTCGGGCGCGGCGACGAGCTGCGCGGTCTGCTGGAGTCCGCGACGTCCGCGTTCCACACCTCGGGGCGGGTGGCGTTCGTCGTCGGCGAGGCGGGCAGCGGCAAGACCCGGCTCCTCTCCGAGTTGGAGCGCTCGGTTCCGGACAGTGTGCGCACCGTCTGGGCGTCCTGTTCGGAGAGTGAGGACCGGCCCGACTACTGGCCGTGGACGACCGTGCTGCGGCATCTGTACGCGATGTGGCCGGAACGTATGCACGGATTCCCCGGTTGGCTGCGGCGCGCACTCGCGGAACTGCTTCCCGAGGTGGGCCCGGAGCCACAGGGGCCGCACTCCCCCGACGGGGGCGAGGAGAACAGCGGCAACGGGGACGGTGCGGGCGACGGGGACAGCACCCCGGCGCACACCCTCACGCTCGCGCCCGCTCTCGCGCCCCCGCGCTCCAGAGAGGCTCGTTTCACCCTGCACGACGCCGTGTGCCAGGCGCTTCTGCGCACGGTCCGCGAACCCGTGGTGATCATGCTGGAGGACATGGAGCGGGCCGACGCCCCCTCGCTCGCCCTGCTGCGCCTCCTGGTGGAGCAACTGCGCACCGTCCCCCTGCTGCTCGTGGTCACCACGCGCACCTTCCGGCTCGCGCACGACGCCGAGCTGCGACGGGCCGCCGCCGTGATCCTCCAGTCGACCGGCGCGCGCCGGGTCCTGCTGAACGCCCTGGACGCACGGGCCACCGGGGAACTCGCCGGAGGGATGCTGGGCAAGGCCCCGGACACCCTCCTCGTACGGGCCCTGCACGAGCGCTCCGCCGGGAACCCGTACTTCCTCGTCCAGCTCCTCCGCTCGCTCCGGCAGGGGCTCGCCGCCGCCTGGGAGACGGAGATCCCGGACGAGCTGGCCGGGGTCGTGCTGCAACGGCTGTCGAGCGTGCCGCCCGCCGTGCGCCGGGTGCTCGACATCTGCGCGGTCGTGGAGCGCAGTTGCGAACGGCGTGTGATCGAGACCGTGCTGCGCCATGAGGGAATCCCGCTGGAGAACGTCCGTACGGCGGTCCGCGGCGGTCTGCTGGAGGAAGACCCCGACGACCCCGGGCGGCTGAGGTTCGTGCATCCGCTGGTCCGGGAGGCCGTCTGGGACGACCTGGAGAACACCCGTCGGCCCGTGTCCCGTTCCTCCGCGCTCGGGGCGCTGGCCACGGTCTGA	MSDVFASEKSSPGVRTRAATSPPRSVISAVGAVSHAEKIGYAVYECSDEVRHDVPGLPGPSPSITVLGCLGVRADGRKLELGPPRQRAVFALLLINAGSVVPVDSIVFRIWGNSPPGAVTATLQSYVSRLRKLLAECVLPDGSTPELLHQPPGYTLALGTEHIDANRFEQAIRTGRRLSREEQHQEARAVLCQALLSWGGTPYEELSAYDFAVQEANRLEQLRLGAVETWAHCCLRLGRDEEVMDQLKPEVQRNPLRERLIGQLMQAQYRLGCQADALRTYEATRRALAEELGTDPGKELAALHAAILRQDNGLDRVVPASAPPSAGVGRGAVTVSVPAQRSRPLTRPVAGRARVPGAMTVAAGAGAAPASASGSVSASVSGSGSGSGSAPASVPTFFPGSVSGSASVAASVAAPVSGHVSGPGSAFGSVALHRPQTLRGEPVHGGAQGMRTGQVFPTLPPFVGRGDELRGLLESATSAFHTSGRVAFVVGEAGSGKTRLLSELERSVPDSVRTVWASCSESEDRPDYWPWTTVLRHLYAMWPERMHGFPGWLRRALAELLPEVGPEPQGPHSPDGGEENSGNGDGAGDGDSTPAHTLTLAPALAPPRSREARFTLHDAVCQALLRTVREPVVIMLEDMERADAPSLALLRLLVEQLRTVPLLLVVTTRTFRLAHDAELRRAAAVILQSTGARRVLLNALDARATGELAGGMLGKAPDTLLVRALHERSAGNPYFLVQLLRSLRQGLAAAWETEIPDELAGVVLQRLSSVPPAVRRVLDICAVVERSCERRVIETVLRHEGIPLENVRTAVRGGLLEEDPDDPGRLRFVHPLVREAVWDDLENTRRPVSRSSALGALATV	MENLAVNITNLQVRFGNQLELSIDSLRVYQQDRIGIIGENGVGKTTLLKLIVGELIPNQGKIQTEITFNYLPQLTYLAEAKDLNLELASHFQLKLEETSERKWSGGEERKIELIRLLSSYEQGMLLDEPTTHLDRKSMDRLIEELRYYYGTLIFVSHDRYFLDELATKVWEVKDGEIREFPENYSAYLTQRELEKKTQLREAESIMKEKKRLEKSIQEKKKQAEKLEKVSSKKKKQQIRPDRLSSSKQKDSVQKAIQKNTKTLERRLQKIGETTKPQQMKQIRFPVPKSLELHNRYPIMGQNIQLERSGRTLLINSDFQFSLGKKIAIVGENGSGKTTLLEHIRKQGEGILLSPKVSFQVYQQKDYQMTSEESVIRFVMRQTEFSESLVRSLLNHLGFAQETLTKPLCTLSGGEATRLTIALLFTKPSNVLLLDEPTNFIDVATIEALEQLMQVYPGTILFTSHDSYFVERTADEVYEIKGQKIKKVLTRNF	174.80	gnl|BL_ORD_ID|1891|hsp_num:0	2054			888	1038	erythromycin; quinupristin
